PIC/S adopts EU GDP Guidelines
Recommendation
6/7 November 2024
Temperature controlled Transports of Medicinal Products
The Pharmaceutical Inspection Co-operation Scheme PIC/S has published a PIC/S Guide to Good Distribution Practice for Medicinal Products (PE 011-1). This Guide is based on the EU GDP-Guidelines (2013/C 343/01) and quotes the EU Guide almost completely.
However, EU specific references have been deleted and the term "must" is often replaced by the term "should". A dedicated Responsible Person is not introduced by the PIC/S document. It talks about "designated responsible person(s)" or "designated person(s)". Chapter 2.2 "Responsible person" of the EU GDP Guide is not quoted in the PIC/S document.
Also import activities are covered by the PIC/S Guide. EU GDP Chapter 5.9 "Export to third countries" has been amended and also covers import activities. Chapter 10 "Specific provisions for brokers" has been deleted completely.
The structure of the PIC/S document has been aligned with the structure of the EU GMP Guidelines, including 9 chapters:
- Chapter 1 Quality Management
- Chapter 2 Personnel
- Chapter 3 Premises and Equipment
- Chapter 4 Documentation
- Chapter 5 Operations
- Chapter 6 Complaints, Returns, Suspected Falsified Medicinal Products and Medicinal Product Recalls
- Chapter 7 Outsourced Activities
- Chapter 8 Self-Inspections
- Chapter 9 Transportation
As with the EU Guidelines, Risk Assessments will become a key tool for implementation of the new requirements.
PE 011-1 is now an official PIC/S guidance document. This does not mean that it is automatically in force in all PIC/S member states. It is a non-binding guidance and PIC/S Participating Authorities need to decide whether it should become a legally-binding standard and then implement it accordingly. Implementation should take into consideration national legislation. In some PIC/S countries for example, importation may fall under GMP and a manufacturer's license may be required.
Currently, PIC/S has 46 Participating Authorities, including most EU Member States, Switzerland, Japan and the USA.
Related GMP News
10.10.2024SwissGMDP Database now available
10.10.2024New MHRA Guidance for Wholesalers and Manufacturers
10.10.2024Abbreviations used in the GDP Environment
10.09.2024Checklist for Implementation of GDP Principles - Part 10: Specific Provisions for Brokers
10.09.2024Swissmedic updates Responsible Person Requirements
10.09.2024PDA publishes Technical Report on Last Mile Distribution